Definitive Healthcare Corp. DH Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $238.26M-3.9% | $241.52M-4.2% | $242.28M-5.3% | $244.93M-5.2% | $247.91M-3.0% | ||
| $37.17M-9.5% | $37.95M-6.7% | $38.98M-0.5% | $39.99M+5.9% | $41.09M+14.4% | ||
| $201.09M-2.8% | $203.57M-3.8% | $203.3M-6.2% | $204.94M-7.2% | $206.82M-5.9% | ||
| 84.4%+1.0pp | 84.3%+0.4pp | 83.9%-0.8pp | 83.7%-1.7pp | 83.4%-2.5pp | ||
| $31.97M-10.4% | $34.78M-4.8% | $33.8M-13.6% | $33.53M-21.3% | $35.69M-16.4% | ||
| $80.56M-2.6% | $81.64M-2.6% | $81.87M-5.9% | $81.62M-9.0% | $82.7M-11.0% | ||
| $51.44M+15.2% | $51.63M+4.8% | $45.81M-20.1% | $44.8M-26.0% | $44.65M-27.6% | ||
| $35.62M-3.3% | $35.82M-4.8% | $36.02M-5.6% | $36.42M-5.3% | $36.82M-4.9% | ||
| $216.75M-75.0% | $196.06M-71.5% | $273.59M— | $501.74M— | $865.39M— | ||
| $421.94M-60.6% | $407.55M-55.1% | $481.18M-41.6% | $700.89M-22.0% | $1.07B+97.9% | ||
| $421.94M-60.6% | $407.55M-55.1% | $481.18M-41.6% | $700.89M-22.0% | $1.07B+97.9% | ||
| -$240.78M+72.6% | -$224.27M+68.4% | -$297.21M+52.2% | -$513.89M+25.7% | -$879.36M-163% | ||
| -101.1%+254pp | -92.9%+189pp | -122.7%+120pp | -209.8%+57.7pp | -354.7%-224pp | ||
| $11.48M-14.6% | $11.29M-23.9% | $11.93M-21.6% | $12.68M-17.5% | $13.45M-12.7% | ||
| $6.2M-51.3% | $6.95M-52.4% | $8.68M-42.8% | $10.75M-27.8% | $12.72M-13.7% | ||
| $1.71M-98.2% | $15.02M-80.5% | $14.54M-78.7% | $46.94M-36.1% | $93.13M+202% | ||
| $0+100% | -$507K— | -$507K— | -$507K— | -$507K— | ||
| -$239.07M+69.6% | -$209.26M+67.0% | -$282.67M+49.1% | -$466.95M+24.7% | -$786.23M-158% | ||
| -$2.51M+95.2% | -$9.96M+76.5% | -$15.8M+56.6% | -$30.05M+25.3% | -$52.41M-165% | ||
| -$170.33M+66.7% | -$138.93M+66.4% | -$188.69M+48.2% | -$304.75M+24.7% | -$510.83M-156% | ||
| -71.5%+135pp | -57.5%+106pp | -77.9%+64.5pp | -124.4%+32.2pp | -206.1%-128pp | ||
| -$1.63+63.0% | -$1.26+64.3% | -$1.68+45.5% | -$2.66+23.1% | -$4.40-154% | ||
| -$1.63+63.0% | -$1.26+64.3% | -$1.68+45.5% | -$2.66+23.1% | -$4.40-154% | ||
| 421.9M-9.0% | 430M-8.2% | 440M-5.2% | 452.6M-2.1% | 463.6M+1.5% | ||
| 421.9M-9.0% | 430M-8.2% | 440M-5.2% | 452.6M-2.1% | 463.6M+1.5% | ||
| $19.93M+24.7% | $20.29M+44.4% | $19.33M+44.3% | $17.94M+37.5% | $15.98M+25.3% | ||
| $5.59M+12.9% | $7.62M-37.6% | $10.08M-10.1% | $2.78M-83.4% | $4.96M-71.6% | ||
| $7.56M-92.1% | $21.71M-71.8% | $19.38M-71.6% | $50.7M-31.1% | $95.31M+209% | ||
| $216.75M-75.0% | $196.06M-71.5% | $273.59M— | $501.74M— | $865.39M— | ||
| $6.2M-51.3% | $6.95M-52.4% | $8.68M-42.8% | $10.75M-27.8% | $12.72M-13.7% | ||
| $1.71M-98.2% | $15.02M-80.5% | $14.54M-78.7% | $46.94M-36.1% | $93.13M+202% | ||
| -$240.78M+72.6% | -$224.27M+68.4% | -$297.21M+52.2% | -$513.89M+25.7% | -$879.36M-163% | ||
| -$237.06M+73.0% | -$220.97M+68.8% | -$294.37M+52.4% | -$511.34M+25.8% | -$877.08M-164% | ||
| -$237.06M+73.0% | -$220.97M+68.8% | -$294.37M+52.4% | -$511.34M+25.8% | -$877.08M-164% | ||
| -99.5%+254pp | -91.5%+189pp | -121.5%+120pp | -208.8%+57.9pp | -353.8%-224pp | ||
| -$240.78M+72.6% | -$224.27M+68.4% | -$297.21M+52.2% | -$513.89M+25.7% | -$879.36M-163% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Definitive Healthcare Corp.'s revenue?
- Definitive Healthcare Corp. (DH) generated $238.3M in revenue over the trailing twelve months, down 3.9% year over year.
- Is Definitive Healthcare Corp. profitable?
- Definitive Healthcare Corp. is not currently profitable: it reported a net loss of $170.3M over the trailing twelve months, a -71.5% net margin.
- What are Definitive Healthcare Corp.'s profit margins?
- Gross margin is 84.4% and operating margin is -101.1%, with a -71.5% net margin.
- What is Definitive Healthcare Corp.'s earnings per share?
- Definitive Healthcare Corp.'s diluted EPS over the trailing twelve months is $-1.63.
- Where does Definitive Healthcare Corp.'s income statement data come from?
- Every line is extracted from Definitive Healthcare Corp.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
